Literature DB >> 16150371

A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patients.

Vincent Wai-Sun Wong1, Man-Yee Law, Alex Yui Hui, Angeline Oi-Shan Lo, Cheuk-Yin Li, Man-Tak Soo, Hor-Yee Leung, Henry Lik-Yuen Chan.   

Abstract

OBJECTIVES: To survey the pattern of traditional Chinese medicine usage among chronic hepatitis B patients.
DESIGN: Self-administered questionnaire survey.
SETTING: Hepatitis clinic at a university hospital in Hong Kong. MAIN OUTCOME MEASURES: Proportion of chronic hepatitis B patients who have ever used traditional Chinese medicine for the treatment of chronic hepatitis B and factors associated with the use.
RESULTS: Three hundred and sixty-two patients completed the survey (response rate 93%). One hundred and sixteen (32%) patients reported history of traditional Chinese medicine usage. One hundred and five (91%) patients felt that Chinese medicine had few or no side effects. Most (81%) patients did not inform their physicians on Chinese medicine usage. On multivariate analysis, recent travel to Mainland China, perceived active hepatitis and family members with chronic hepatitis B were independent factors associated with the use of Chinese medicine.
CONCLUSIONS: Chronic hepatitis B patients commonly use traditional Chinese medicine. As patients seldom inform the physicians about the use of Chinese medicine, doctors should explicitly enquire about this because of potential therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150371     DOI: 10.1016/j.ctim.2005.04.006

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  13 in total

Review 1.  Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies.

Authors:  Vincent C H Chung; Polly H X Ma; Chun Hong Lau; Samuel Y S Wong; Eng Kiong Yeoh; Sian M Griffiths
Journal:  Health Expect       Date:  2012-05-31       Impact factor: 3.377

2.  Isoschaftoside Reverses Nonalcoholic Fatty Liver Disease via Activating Autophagy In Vivo and In Vitro.

Authors:  Yanze Su; Yixing Kang; Jing Yi; Qirui Lin; Chaochuang Zhang; Zewei Lin; Zilong Yan; Jianhua Qu; Jikui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-27       Impact factor: 2.650

3.  Risk of liver injury associated with Chinese herbal products containing radix bupleuri in 639,779 patients with hepatitis B virus infection.

Authors:  Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

4.  Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.

Authors:  De Zhao Kong; Ning Liang; Guan Lin Yang; Zhe Zhang; Yue Liu; Jing Li; Xuehan Liu; Shibing Liang; Dimitrinka Nikolova; Janus C Jakobsen; Christian Gluud; Jian Ping Liu
Journal:  Cochrane Database Syst Rev       Date:  2019-11-07

5.  Polysaccharides From Abrus cantoniensis Hance Modulate Intestinal Microflora and Improve Intestinal Mucosal Barrier and Liver Oxidative Damage Induced by Heat Stress.

Authors:  Ying Wang; Wenjing Sun; Enyun Wu; Kaijun Wang; Xiaogang Chen; Yao Cui; Geyin Zhang; Feifei Lv; Yuhan Wang; Xiaomin Peng; Hongbin Si
Journal:  Front Vet Sci       Date:  2022-04-04

Review 6.  Antiviral therapy for chronic hepatitis B in China.

Authors:  Xin Zheng; Junzhong Wang; Dongliang Yang
Journal:  Med Microbiol Immunol       Date:  2014-12-25       Impact factor: 3.402

7.  The Effects of Different Purifying Methods on the Chemical Properties, in Vitro Anti-Tumor and Immunomodulatory Activities of Abrus cantoniensis Polysaccharide Fractions.

Authors:  Shaowei Wu; Xiong Fu; Margaret A Brennan; Charles S Brennan; Chen Chun
Journal:  Int J Mol Sci       Date:  2016-04-06       Impact factor: 5.923

8.  An investigation of the use of traditional chinese medicine in stroke patients in taiwan.

Authors:  Chien-Chang Liao; Jaung-Geng Lin; Chin-Chuan Tsai; Hsin-Long Lane; Ta-Chen Su; Hwang-Huei Wang; Fung-Chang Sung; Ta-Liang Chen; Chun-Chuan Shih
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-11       Impact factor: 2.629

9.  Efficacy and safety of a chinese herbal formula (invigorating kidney and strengthening spleen) in chronic hepatitis B virus carrier: results from a multicenter, randomized, double-blind, and placebo-controlled trial.

Authors:  Jinsong He; Daqiao Zhou; Guangdong Tong; Yufeng Xing; Yingjie Chen; Xiaohui Zhang; Bolin Zhan; Hui Gao; Xiaozhou Zhou; Yiqun Xiong; Xinliang Liu; Lisheng Peng; Mei Qiu; Yingjun Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-10       Impact factor: 2.629

10.  Comparative Evaluation between Sulfasalazine Alone and in Combination with Herbal Medicine on DSS-Induced Ulcerative Colitis Mice.

Authors:  Mi-Rae Shin; Kyeong Jo Kim; Soo Hyun Kim; Su Ji Kim; Bu-Il Seo; Hyo-Jin An; Seong-Soo Roh
Journal:  Biomed Res Int       Date:  2017-09-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.